Global index to summarise health risks versus benefit in the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial

被引：0

|

作者：

Howell, A.

机构：

来源：

EJC SUPPLEMENTS | 2005年 / 3卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：98 / 98

页数：1

相关论文

共 50 条

[21] Efficacy data from the ATAC ("arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment
不详
BREAST, 2005, 14 : S51 - S51
[22] Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial
Duffy, SRG
Taylor, L
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (06) : 1921 - 1927
[23] ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial-anastrozole is superior to tamoxifen as adjuvant treatment in postmenopausal women with early breast cancer.
Bianco, R
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S155 - S155
[24] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women:: a sub-protocol of the 'Arimidex™ and Tamoxifen Alone or in Combination' (ATAC) trial
Baum, M
Dowsett, M
Coibion, M
Bianco, AR
Cuzick, J
George, WD
Gray, J
Howell, A
Houghton, J
Williams, N
Sloane, J
Tobias, J
Buzdar, A
Anderson, MD
Jackson, I
Sahmoud, T
Gallagher, J
Webster, A
Gangji, D
Petrakova, K
Konopasek, B
Mares, P
Vodvarka, P
Alcazar, A
Campos, O
Maxwell, A
Goedhals
Hacking, D
Landers, G
Smith, L
Vorobiof, DA
Werner, ID
Blamey, R
Coleman, R
Grieve, RJ
Hickish, T
Howell, A
Nicholls, JC
Nicholson, S
Raymond, S
Salman, A
Blum, J
Clark, R
Lyss, A
Miletello, G
Sternberg, J
Forbes, J
Coibion, M
Nabholtz, JM
Guastalla, JP
BRITISH JOURNAL OF CANCER, 2001, 85 (03) : 317 - 324
[25] The ATAC ('Arimidex', Tamoxifen, alone or in combination) early breast cancer trial in postmenopausal patients: endometrial sub-protocol results
Duffy, S
Jackson, T
INTERNATIONAL JOURNAL OF CANCER, 2002, : 137 - 138
[26] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
British Journal of Cancer, 2001, 85 : 317 - 324
[27] Analysis of fracture risk factors from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial: 5-year data.
Howell, A.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 18S - 18S
[28] Effect of anastrozole on bone mineral density: 5-year results of the 'Arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) trial
不详
CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S25 - S25
[29] Effect of anastrozole on bone mineral density and bone fractures: results from the 'Arimidex' (anastrozole), Tamoxifen, Alone or in Combination (ATAC) trial
Coleman, R.
EJC SUPPLEMENTS, 2004, 2 (03): : 140 - 140
[30] Effect of anastrozole on bone mineral density: 2-year results of the 'arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) trial
Howell, A
BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S27 - S27

← 1 2 3 4 5 →